Giuseppe Del Priore
Overview
Explore the profile of Giuseppe Del Priore including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
437
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Leonis R, Chavez T, Caldwell A, Del Priore G, Matthews R, Franklin C
Am Surg
. 2025 Feb;
:31348251318376.
PMID: 39924688
Significant disparities exist in women with endometrial cancer. Disparate incidence and mortality rates affect many populations including racial/ethnic minority women and women who live in rural communities. These populations are...
2.
Wiseman C, Holmes J, Calfa C, Dakhil S, Bhattacharya S, Peoples G, et al.
Hum Vaccin Immunother
. 2024 Aug;
20(1):2379864.
PMID: 39165083
This Phase I/IIa open-label, single-arm clinical trial addressing advanced, refractory, metastatic breast cancer was conducted at six medical centers in the United States. We repeated inoculations with irradiated SV-BR-1-GM, a...
3.
Tiwari A, Alcover K, Carpenter E, Thomas K, Krum J, Nissen A, et al.
Hum Vaccin Immunother
. 2024 Mar;
20(1):2323256.
PMID: 38544385
Cell-based therapeutic cancer vaccines use autologous patient-derived tumor cells, allogeneic cancer cell lines or autologous antigen presenting cells to mimic the natural immune process and stimulate an adaptive immune response...
4.
Chavez T, Snyder R, Lee R, Mosunjac M, Del Priore G
Int J Gynecol Cancer
. 2023 Jul;
33(9):1487.
PMID: 37419513
No abstract available.
5.
Cottrell C, Ohaegbulam G, Smith J, Del Priore G
Best Pract Res Clin Obstet Gynaecol
. 2021 Apr;
75:72-81.
PMID: 33846052
In the last two decades, great strides have been made to treat cancer while sparing fertility for young women. This is at least partly in response to changing demographics, including...
6.
Gartrell B, Roach 3rd M, Retter A, Sokol G, Del Priore G, Scher H
Invest New Drugs
. 2020 Sep;
39(2):499-508.
PMID: 32924093
Background Androgen deprivation therapy (ADT) is a standard treatment for high-risk biochemically-recurrent, non-metastatic prostate cancer (BRPC) but is not curative and associated with toxicity. Racemetyrosine (SM-88) is an amino-acid analogue...
7.
Timoteo-Liaina I, Khozaim K, Chen Y, Buenconsejo-Lum L, Arslan A, Matthews R, et al.
Int J Gynaecol Obstet
. 2020 Mar;
153(2):330-334.
PMID: 32112712
Objective: To assess the contemporary incidence of cancers using American Samoa as a learning set for insights into similar populations. Methods: A retrospective observational analysis of de-identified data held in...
8.
Stega J, Noel M, Vandell A, Stega D, Del Priore G, Hoffman S
Invest New Drugs
. 2019 Apr;
38(2):392-401.
PMID: 30929156
Purpose SM-88 (D,L-alpha-metyrosine; racemetyrosine) is a novel anti-cancer agent, used with melanin, phenytoin, and sirolimus (SMK Therapy). This pilot first-in-human study characterized the safety, tolerability, and efficacy of SMK Therapy...
9.
10.
Saso S, Jones B, Bracewell-Milnes T, Huseyin G, Boyle D, Del Priore G, et al.
Future Sci OA
. 2017 Sep;
3(3):FSO208.
PMID: 28884005
Grief and hope are two conflicting emotions that a patient recently diagnosed with cancer has to master. The real challenge for gynecologic oncologists is how to reach out. Conventional wisdom...